Logotype for Aditya Birla Capital Limited

Aditya Birla Capital (ABCAPITAL) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Aditya Birla Capital Limited

Q3 25/26 earnings summary

9 Jul, 2026

Executive summary

  • Consolidated revenue for Q3 FY26 rose 30% year-over-year to ₹14,181 crore, with profit after tax up 41% to ₹983 crore, excluding exceptional items.

  • Lending portfolio grew 30% year-over-year to ₹1,90,386 crore; total AUM across AMC, life, and health insurance increased 19% year-over-year to ₹5,98,166 crore.

  • Strong digital adoption and omnichannel platforms have driven customer engagement, operational efficiency, and productivity.

  • Major capital infusion of ₹2,750 crore in the housing finance subsidiary from Advent International, valuing the business at ₹19,250 crore post-money.

  • Board approved unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025.

Financial highlights

  • Standalone profit after tax (excluding exceptional items) grew 24% year-over-year to ₹749 crore; consolidated Q3 FY26 revenue from operations: ₹11,952.09 crore; profit after tax attributable to owners: ₹945.02 crore.

  • Lending (excluding HFC) PAT grew 30% year-over-year to ₹1,047 crore; HFC PAT surged 115% to ₹236 crore.

  • Asset management PAT increased 20% year-over-year to ₹270 crore; Life insurance PAT doubled to ₹86 crore.

  • Health insurance loss narrowed to ₹67 crore from ₹81 crore year-over-year.

  • Standalone ROE improved to 15.2% in Q3 FY26 from 13.2% in Q3 FY25.

Outlook and guidance

  • NBFC loan book expected to grow at 24-25% annually, aiming to double in three years.

  • Housing finance ROA target of 2.1-2.2% expected to be achieved ahead of schedule.

  • Continued focus on digital transformation, operating leverage, and expanding market share while maintaining asset quality.

  • Targeting further market share gains and improved ROA across business lines.

  • Housing finance subsidiary to receive ₹2,750 crore capital infusion from Advent International, pending regulatory approvals, to support growth and market share expansion.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more